Printer Friendly

BIO-VASCULAR REPORTS FIRST QUARTER GAINS IN SALES AND NET INCOME

 BIO-VASCULAR REPORTS FIRST QUARTER GAINS IN SALES AND NET INCOME
 ST. PAUL, Minn., March 2 /PRNewswire/ -- Bio-Vascular, Inc. (NASDAQ: BVAS) today reported sales of $913,667 for its first quarter ended Jan. 31, 1992, an increase of 23 percent over sales of $742,868 for the first quarter of last year.
 Net income was $61,676, equal to one cent per share, compared with $4,135 in the quarter ended Jan. 31, 1991.
 "Sales of all products showed good increases, with especially strong contributions from the Dardik Biograft(R), a peripheral vascular graft, and our new Robicsek Vascular Probe(TM)," said John H. Darnall, president and CEO.
 Bio-Vascular, Inc., based in St. Paul, is a manufacturer and marketer of proprietary consumable medical products for cardiac and vascular surgery.
 BIO-VASCULAR, INC.
 (Unaudited)
 Three Months Ended
 1/31/92 1/31/91
 Net sales $913,667 $742,868
 Net income $61,676 $4,135
 Net income per common share $0.01 $0.00
 Weighted average number of shares
 outstanding 5,556,082 3,867,650
 -0- 3/2/92
 /CONTACT: John H. Darnall, Jr., or M. Karen Gilles, 612-631-3529, both of Bio-Vascular/
 (BVAS) CO: Bio-Vascular, Inc. ST: Minnesota IN: MTC SU: ERN


AL -- MN009 -- 3881 03/02/92 10:57 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 2, 1992
Words:209
Previous Article:PARAMAX RECEIVES $45 MILLION IN NEW AIR TRAFFIC CONTROL BUSINESS
Next Article:AMERICA HAS SAVED $1 BILLION WITH MCI; NATIONAL BILLBOARD CAMPAIGN EXPANDS TO 17 CITIES
Topics:


Related Articles
BIO-VASCULAR REPORTS GAINS IN THIRD QUARTER SALES, NET INCOME
ARROW INTERNATIONAL, INC. REPORTS ON MEETING WITH SECURITY ANALYSTS
BIO-VASCULAR REPORTS GAINS IN FIRST QUARTER SALES, NET INCOME
BIO-VASCULAR REPORTS 2ND QUARTER RESULTS
BIO-VASCULAR REPORTS HIGHER INCOME IN THIRD QUARTER
BIO-VASCULAR REPORTS 1ST QUARTER RESULTS
BIO-VASCULAR REPORTS REVENUE INCREASES FOR 4TH QUARTER, YEAR
BIO-VASCULAR REPORTS PROFIT IN SECOND QUARTER
BIO-VASCULAR REPORTS 1ST QUARTER EPS OF 2 CENTS, UP FROM LOSS IN YEAR-AGO QUARTER
Bio-Vascular Reports Loss For Third Quarter Of 1996

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters